Medifast (MED) PT Lowered to $80 at DA Davidson
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $12.53 --0%
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 13 | New: 4
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 13 | New: 4
Join SI Premium – FREE
DA Davidson analyst Linda Bolton Weiser lowered the price target on Medifast (NYSE: MED) to $80.00 (from $93.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Ambit Capital Upgrades GE Vernova T&D India (GVTD:IN) to Buy (1)
- Advanced Energy Industries (AEIS) PT Lowered to $310 at Wells Fargo
- Ibotta Inc (IBTA) PT Raised to $49 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
